Susan G. Komen Targeting Full Spectrum of Cancer Treatment with $58 Million in 2012 Research Grants

Susan G. Komen for the Cure®’s 2012 research program takes aim at early and late stage breast disease while seeking answers in early detection, cancer prevention, and socioeconomic issues that often make breast cancer outcomes worse in minority and medically under-served women.

Over $1.25 million was granted to researchers at Vanderbilt University.  This outstanding amount is in addition to $2.8 million in Komen research grants already active at the University – totaling over $4 million.

Komen announced a total of $58 million in new international research funding for 2012, augmenting the $685 million that the organization has invested in breast cancer research since 1982. Komen is the largest funder of breast cancer research outside of the U.S. government.

The Komen 2012 research program includes 154 grants to researchers in 22 states and seven countries. Komen currently funds more than 500 active research grants around the world.

The 2012 grants cover the full “continuum of cancer care” including research into prevention, environmental issues, more sensitive screening, personalized treatments and factors that lead to worse breast cancer outcomes in minorities and special populations.

A complete list of Komen’s new peer-reviewed grants is available on Komen’s website at:  www5.komen.org/2012grants.html